Early test for new generic version of bone drug
NCT ID NCT07497503
Summary
This is an early-stage study to see if a new drug called B-3E07 acts similarly to the existing osteoporosis drug Forsteo in the body. It will involve 48 healthy adult women who will receive both drugs in a random order. The main goal is to compare how the body absorbs and processes each drug and to check for any safety issues or immune reactions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Veritus Research
Bayswater, Victoria, 3153, Australia
Conditions
Explore the condition pages connected to this study.